Novo Nordisk
NVO
NVO
1,395 hedge funds and large institutions have $16.1B invested in Novo Nordisk in 2025 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 443 increasing their positions, 563 reducing their positions, and 181 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $16.7B → $16.1B (-$590M)
21% less repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 563
37% less call options, than puts
Call options by funds: $2.04B | Put options by funds: $3.26B
Holders
1,395
Holding in Top 10
19
Calls
$2.04B
Puts
$3.26B
Top Buyers
| 1 | +$247M | |
| 2 | +$220M | |
| 3 | +$219M | |
| 4 |
Goldman Sachs
New York
|
+$219M |
| 5 |
Millennium Management
New York
|
+$81.4M |
Top Sellers
| 1 | -$333M | |
| 2 | -$208M | |
| 3 | -$159M | |
| 4 |
JP Morgan Chase
New York
|
-$95.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$78.5M |
